IDENTIFICATION OF THE ACTIVE-SITE NUCLEOPHILE IN NUCLEOSIDE 2-DEOXYRIBOSYLTRANSFERASE AS GLUTAMIC-ACID-98

被引:48
作者
PORTER, DJT [1 ]
MERRILL, BM [1 ]
SHORT, SA [1 ]
机构
[1] WELLCOME RES LABS,DIV BIOANALYT SCI,RES TRIANGLE PK,NC 27709
关键词
D O I
10.1074/jbc.270.26.15551
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
2'-FIuoro-2'-deoxyarabinonucleosides are time-dependent inhibitors of nucleoside 2-deoxyribosyltransferase. 2,6-Diamino-9-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-9H-purine (dFDAP) inhibited the enzyme by formation of a primary complex (K-d = 140 mu M) that isomerized to a secondary complex with a first-order rate constant of 0.2 min(-1). Inhibited enzyme contained stoichiometric amounts of covalently bound 2'-fluoro-2'-deoxyarabinosyl moiety, recovered less than 5% of its activity after storage for a week at 5 degrees C, but regained over 70% of the lost activity by treatment with 600 mu m Ade. 6-Amino-9-(2'-deoxy-2'-fluoro-beta-D-arabinosyl)-9H-purine (dFAdo) was a product of the reactivation reaction. Proteolysis of inhibited enzyme identified a modified fragment that spanned residues 82-107 which could not be sequenced past Gly-96. dFDAP inhibited enzyme and enzyme reacted with normal substrates (i.e. dThd and dAdo) were hydrolyzed between Met-97 and Glu-98 by 0.1 M NaOH, These findings and model studies on the base lability of peptides containing glutamyl esters suggested that the gamma-carboxylate of Glu-98 was esterfied during catalysis. The role of Glu-98 was confirmed by changing this residue to alanine. The spe cific activity of wild-type enzyme was 3 orders of magnitude greater than that of the mutant enzyme. Collectively, chemical modification and mutagenesis studies have identified Glu-98 as the active site nucleophile of nucleoside 2-deoxyribosyltransferase.
引用
收藏
页码:15551 / 15556
页数:6
相关论文
共 40 条
  • [1] Holguin J., Cardinaud R., FEBS Lett., 20, pp. 171-173, (1972)
  • [2] Danzin C., Cardinaud R., Eur. J. Biochem., 48, pp. 255-262, (1974)
  • [3] Holguin J., Cardinaud R., Eur. J. Biochem., 54, pp. 515-520, (1975)
  • [4] Danzin C., Cardinaud R., Eur. J. Biochem., 62, pp. 365-372, (1976)
  • [5] Cardinaud R., Holguin J., Biochim. Biophys. Acta, 668, pp. 339-347, (1979)
  • [6] Huang M.-C., Hatfield K., Roetker A., Montgomery J.A., Blakley R.L., Biochem. Pharmacol., 30, pp. 2663-2671, (1981)
  • [7] Huang M.-C., Montgomery R.A., Thorpe M.C., Stewart E.L., Secrist III J.A., Blakley R.L., Arch. Biochem. Biophys., 222, pp. 133-144, (1983)
  • [8] Smar M., Short S.A., Wolfenden R., Biochemistry, 30, pp. 7908-7912, (1991)
  • [9] Roush A.H., Betz R.F., J. Biol. Chem., 233, pp. 261-266, (1958)
  • [10] Zimmerman M., J. Biol. Chem., 239, pp. 2622-2627, (1964)